Solis Minerals moves forward on Cinto Copper Project
Solis Minerals (ASX:SLM) has provided an update on its 100%-owned Cinto Copper Project in Peru.
Solis Minerals (ASX:SLM) has provided an update on its 100%-owned Cinto Copper Project in Peru.
Iondrive (ASX:ION) announced leadership transition as it moves from technology development to the commercial execution and scale-up of its proprietary IONSolv platform.
Federal Resources Minister and Labor MP for Brand, Madeleine King, has raised concerns over the potential sale of RAC Insurance to east coast giant Insurance Australia Group (ASX:IAG), warning it could undermine vital local services for West Australians.
PolyNovo (ASX:PNV) reported unaudited trading results for the first half of FY26, with group revenue rising 26% to $68.2 million, compared with $54.1 million in the same period last year.
Australian mining magnate Gina Rinehart is extending her empire into the Middle East after securing five gold exploration licences in Saudi Arabia through her Hancock Prospecting subsidiary, Midana Exploration, in partnership with the kingdom’s largest miner, Maaden
City Chic Collective (ASX:CCX) has reported a solid trading update for the 26 weeks to Dec. 28, 2025, delivering global sales revenue of $69.2 million, broadly flat on the prior corresponding period.
Australia's competition watchdog has stepped up pressure on the Albanese government to fast-track legislation that would give it powers to force Apple and Google to open their devices to third-party app stores and alternative payment systems.
BlockDAG is facing mounting investor concern over missing funds, unpaid obligations, and unfulfilled commitments.
Silver has smashed past the US$90 level this month, capping one of the strongest runs of any major asset.
NOVONIX (ASX:NVX), a global leader in battery materials and technology, provided an update on its supply timeline for Panasonic Energy, its lead battery material customer.
Australian heavy rare earths company Northern Minerals (ASX:NTU) has announced encouraging preliminary metallurgical results from its Wolverine-Dazzler Blending Study.
Zelira Therapeutics (ASX:ZLD) has secured US$33 million (before costs) through a strategic fundraising with TGC Biotechnology Fund, into its HOPE 1 special purpose vehicle, bringing total equity raised to US$36.6 million.